Patent · US Active

Rutaecarpine analogs and applications thereof

US10526333B2 · kind B2 · utility

1Cited by
0References
12Claims
0Family size

Assignees

Inventors

Key dates

Filing dateApr 13, 2018
Grant dateJan 7, 2020
Priority date
Expiry dateApr 13, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P29/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides RUT analogs with various biological activities. In particular, the biological activities comprise anti-inflammatory activity, vasodilator effects, migration/invasion-suppressive activities, ability against damage due to remodeling between the epithelium and endothelium, collagen deposition and cardiac fibrosis suppress, Snail protein inhibitory effect, etc., which may improve cardiac, vasodilation, and lung functions. The RUT analogs disclosed herein also exhibit a lower cytotoxicity comparing to RUT.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.